THERAKOS LLC

Therakos, Inc. specializes in the manufacturing and support of extracorporeal photopheresis systems and associated procedural kits, serving critical immunotherapy and clinical care needs within federal healthcare settings. Their core capabilities center on the production of UVADEX (methoxsalen)-based diagnostic substances and photopheresis kits used for treating cutaneous T-cell lymphoma and graft-versus-host disease. The company provides precision-engineered, sterile, single-use kits compliant with cGMP standards and maintains technical expertise in the calibration, servicing, and maintenance of CELLEX photopheresis equipment, ensuring uninterrupted clinical operation. Their differentiation lies in end-to-end support—from manufacturing FDA-regulated pharmaceutical and diagnostic components to delivering on-site maintenance of complex medical devices—enabling seamless integration into hospital and clinical center workflows. Therakos maintains a consistent and deep relationship with the Department of Veterans Affairs and the Department of Health and Human Services, supplying mission-critical photopheresis systems and consumables to VA medical centers and HHS-operated clinical research facilities. These agencies rely on Therakos for emergency replenishment of ECP kits and ongoing equipment servicing, indicating a trusted, operational partnership grounded in reliability and regulatory compliance. The company’s primary industry focus is pharmaceutical preparation manufacturing (NAICS 325412) and in-vitro diagnostic substance manufacturing (NAICS 325413), positioning it as a niche supplier within the immunotherapy and apheresis device market. They also support surgical instrument and medical equipment maintenance (NAICS 339112, 811210), reinforcing their role as a provider of integrated therapeutic and diagnostic solutions for specialized medical procedures. Therakos, Inc. is a privately held manufacturer based in Hazelwood, Missouri, with no federal certifications on record. Its operational footprint is centered on serving federal healthcare systems through direct supply and service agreements, with no indication of broader commercial or international market presence.